Desai S, Tunis M, Stirling R, Jensen C, Ismail S, Baclic O, Lerch R
Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Can Commun Dis Rep. 2016 Dec 1;42(12):252-255. doi: 10.14745/ccdr.v42i12a03.
The National Advisory Committee on Immunization (NACI) provides expert and evidence-based advice to the Public Health Agency of Canada (PHAC) on the use of human vaccines in Canada. This advice is presented in a variety of publications for different uses. A recent survey identified some confusion regarding the various NACI publication products. The objective of this article is to identify the level of detail and appropriate uses of the different NACI products. NACI statements provide a synthesis of current evidence and expert opinion on new vaccines or new indications for vaccines to inform immunization practices, policies and programs. NACI literature reviews inform new NACI statements and are published after the statement to inform readers about current literature on a specific immunization topic. The (CIG) is a practice-oriented guide that synthesizes all the NACI statements and is updated regularly. NACI statement summaries are published in the (CCDR) and provide a high level overview of these statements shortly after they are published. These products provide a variety of options for users to choose how in-depth they wish to explore the evidence base and process for producing recommendations for immunization in Canada.
国家免疫咨询委员会（NACI）就加拿大人类疫苗的使用向加拿大公共卫生署（PHAC）提供基于证据的专家建议。该建议以多种不同用途的出版物形式呈现。最近的一项调查发现，人们对NACI的各种出版物存在一些困惑。本文的目的是确定不同NACI产品的详细程度和适用情况。NACI声明综合了关于新疫苗或疫苗新适应症的当前证据和专家意见，以为免疫实践、政策和项目提供参考。NACI文献综述为新的NACI声明提供信息，并在声明发布后发表，以便向读者介绍关于特定免疫主题的当前文献。《加拿大免疫指南》（CIG）是一份以实践为导向的指南，综合了所有NACI声明，并定期更新。NACI声明摘要发表在《加拿大疾病周报》（CCDR）上，并在声明发布后不久提供这些声明的高层次概述。这些产品为用户提供了多种选择，让他们可以根据自己的意愿深入了解加拿大免疫接种建议的证据基础和制定过程。
